OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(1)
Organisms
Tuwongella immobilis
(1)
Polynucleobacter asymbioticus
(1)
Polynucleobacter asymbioticus QLW-P1DMWA-1
(1)
Acinetobacter baumannii
(1)
Puccinia triticina 1-1 BBBD Race 1
(1)
Capra hircus
(1)
Ceratonova shasta
(1)
Nematoda
(1)
Pocillopora acuta
(1)
Phoca largha
(1)
Glycine max
(1)
Tomato mottle virus
(1)
Ovis aries
(1)
Pteromalus puparum
(1)
Coronavirus PREDICT CoV-19
(1)
Shigella flexneri 5a str. M90T
(1)
Ginglymostoma cirratum
(1)
Cellulomonas fimi
(1)
Mollisia scopiformis
(1)
Cellulomonas sp. B6
(1)
Triticum urartu
(1)
Amphibia
(1)
Oryx dammah
(1)
Mammuthus
(1)
Muridae
(1)
Balaenidae
(1)
Deltacoronavirus PDCoV/USA/Illinois121/2014
(1)
Mycobacterium avium 104
(1)
Ursus sp.
(1)
environmental samples
(1)
Repository
pride
(1)
Tissue
Lung
(1)
Liver
(1)
Disease
Non-small cell lung carcinoma
(1)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2019
(1)
Release Date
2017
(1)
2014
(1)
Lab affiliation
The SCripps Research Institute
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.
Not available
S-EPMC3890870
|
biostudies-literature
Cite
Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors.
Not available
S-EPMC5693604
|
biostudies-literature
Cite
Proteome-wide map of targets of T790M-EGFR-directed covalent inhibitors
Idnetification of the off-targets of several third generation T790M specific inhibtors.
ORGANISM(S):
Homo sapiens (Human)
Mus musculus (Mouse)
2019-11-11
|
PXD007163
|
Pride
Abpp
H1975
Co1686
T790m
Azd9291
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
